Nebula Research & Development LLC Rx Sight, Inc. Transaction History
Nebula Research & Development LLC
- $836 Billion
- Q3 2024
A detailed history of Nebula Research & Development LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 36,423 shares of RXST stock, worth $1.63 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
36,423
Previous 27,952
30.31%
Holding current value
$1.63 Million
Previous $1.68 Billion
7.05%
% of portfolio
0.22%
Previous 0.27%
Shares
4 transactions
Others Institutions Holding RXST
# of Institutions
227Shares Held
32MCall Options Held
57.8KPut Options Held
12.5K-
Ra Capital Management, L.P. Boston, MA3.69MShares$165 Million3.35% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$107 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.29MShares$102 Million0.0% of portfolio
-
Lord, Abbett & Co. LLC Jersey City, NJ1.74MShares$77.5 Million0.34% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.17MShares$52.3 Million0.09% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $1.23B
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...